The Hurone AI Difference

Request a Demo

Transforming Precision Cancer Care & Navigation

Hurone AI redefines oncology care with scalable, reimbursable AI solutions that deliver measurable impact: improving patient outcomes, reducing costs, and driving new revenue opportunities. Our flagship platform, Gukiza, empowers cancer centers with personalized treatment insights, leveraging over 1M+ diverse cancer data points. By cutting oncologist workloads by 50% and reducing operational costs by 30%, Gukiza positions cancer centers for success in value-based care models.

How Hurone AI Stands Out

Hurone AI’s approach is built on a foundation of empathy, innovation, and responsibility.

Explainable and You Can Trust

Every recommendation we provide is evidence-based and fully transparent, enabling clinicians to trust and act on the insights with confidence.

Explainable and You Can Trust

Every recommendation we provide is evidence-based and fully transparent, enabling clinicians to trust and act on the insights with confidence.

Federated Learning for Global Relevance

By training AI across decentralized, secure and diverse data sources including data from underrepresented populations, Hurone AI ensures our solutions are scalable, adaptable, and universally relevant while adhering to the highest privacy and regulatory standards.

Federated Learning for Global Relevance

By training AI across decentralized, secure and diverse data sources including data from underrepresented populations, Hurone AI ensures our solutions are scalable, adaptable, and universally relevant while adhering to the highest privacy and regulatory standards.

Grounded in Evidence and Expertise

We collaborate with leading cancer centers in the U.S, AWS, the National Comprehensive Cancer Network (NCCN®), amongst others, to develop and validate cutting-edge AI that bridges the gap in research and care, ensuring that we are evidence-based in real-time.

Grounded in Evidence and Expertise

We collaborate with leading cancer centers in the U.S, AWS, the National Comprehensive Cancer Network (NCCN®), amongst others, to develop and validate cutting-edge AI that bridges the gap in research and care, ensuring that we are evidence-based in real-time.

Intelligent Patient Navigation

Unlike traditional navigation systems, Hurone AI combines real-time symptom monitoring with predictive analytics from the patient’s data to anticipate patient needs before they arise. We provide a culturally adaptive, hyper-personalized care. Specifically guiding patients through complex treatment plans, addressing side effects, nutritional needs and connecting them to resources.

Intelligent Patient Navigation

Unlike traditional navigation systems, Hurone AI combines real-time symptom monitoring with predictive analytics from the patient’s data to anticipate patient needs before they arise. We provide a culturally adaptive, hyper-personalized care. Specifically guiding patients through complex treatment plans, addressing side effects, nutritional needs and connecting them to resources.
"Federated learning and diverse datasets, like those Hurone AI integrates, are essential for building equitable AI solutions that address the unique needs of diverse patient populations globally. Hurone AI is pioneering this transformative approach in oncology."
Dr. Irene Dankwa-MullanHurone AI Board Member & Former Chief Health Equity Officer, IBM Watson
"Our vision is grounded in people and their realities. We don’t just build AI—we create tools that empower clinicians, reduce financial strain on healthcare systems, and ensure every patient receives timely, personalized care."
Kingsley I. Ndoh, MD, MPHCEO, Hurone AI

Driving Outcomes That Matter

“Our vision is grounded in people and their realities,” says Kingsley I. Ndoh, founder of Hurone AI.
“We don’t just build AI—we create tools that empower clinicians, reduce financial strain on healthcare systems, and ensure every patient receives timely, personalized care.”

By reducing hospitalizations, improving remote monitoring, and automating workflows, Hurone AI delivers AI solutions that meet the real-world needs of patients and clinicians. Pharmaceutical partners leverage diverse real-world data from Hurone to improve cancer drug development and safety.

Request a Demo

Bridging the Gap in Cancer Care

In a rapidly evolving industry, Hurone AI’s commitment to scalability, interoperability, financial impact, and health equity sets us apart.

  • We reduce costs for resource-constrained centers by automating workflows and optimizing staffing.
  • We enable new revenue streams through partnerships with pharmaceutical companies and clinical trials.
  • We leverage diverse, multimodal datasets to ensure AI solutions are robust, inclusive, and designed for the real-world needs of patients and clinicians.
Request a Demo

Leading the Future of Oncology Innovation

Hurone AI envisions a world where AI-powered precision care transforms lives and redefines healthcare economics. By blending federated learning, actionable insights, and mission-driven partnerships, we are building a future that is equitable, efficient, and impactful. Join us as we revolutionize cancer care and create a future where no patient is left behind.

Click below to See Hurone’s contributions to the President’s Cancer Panel, submitted to the President of the United States
View HURONE'S CONTRIBUTIONS
"Our focus is on creating AI that drives results—financially, clinically, and operationally."
Kingsley I. Ndoh, MD, MPHCEO, Hurone AI
"By understanding the unique challenges of healthcare systems, we design solutions that deliver meaningful value to all stakeholders."
Kingsley I. Ndoh, MD, MPHCEO, Hurone AI

Lets Book a Demo

Floria Nyandaya

Research Fellow | Program Manager, Hurone AI

Floria Nyandaya is a physician-scientist dedicated to tackling health disparities in non-communicable diseases(NCDs) amidst Africa’s epidemiological transition. 

With a diverse background in primary clinical practice, healthcare management, infectious disease surveillance and NCD research, she has recently expanded her focus to digital health technologies. As a recipient of the Cardiometabolic Research Fellowship and the Thomas Francis Jr. Global Health Fellowship in her MPH program, Floria gained hands-on global health experience in the U.S., Nigeria, and Kenya. 

Her research endeavors have been multifaceted, from advancing women’s cardiovascular health to exploring the utility of artificial intelligence in enhancing renal and cancer care and addressing diversity gaps in clinical trial research. Continuously driven by her passion for making a tangible difference, Floria remains dedicated to improving the health and well-being of underserved populations.

 
Marko Stanojević

Engineering Product Manager, Hurone AI

Marko is the Engineering Product Manager at Hurone AI. He has a Bachelor of Science in Computer Science from the Belgrade Institute of Technology. His expertise in software engineering and product development plays a key role in Hurone AI’s success.

Marko’s ability to bridge technology and user experience has been vital in driving the launch of Hurone AI’s innovative products. His collaborative approach and adaptability ensure that the company’s solutions meet the highest standards.

Outside of work, Marko is passionate about technology and stays updated on the latest industry trends. His commitment to continuous learning makes him an invaluable asset to the Hurone AI team.